Cymbalta / Duloxetine
Eli Lilly and Co. is continuing to conduct safety trials of its experimental depression drug Cymbalta, also known as duloxetine, after a healthy 19-year-old college student killed herself while taking the medication. Traci Johnson was one of 22 volunteers involved in a trial at Eli Lilly's clinic at Indiana University Medical Center in Indianapolis. Johnson, who did not have depression, was taken off the drug and given a placebo four days before she hung herself in one of the clinic's showers on February 7, 2004. The trial is testing whether higher-than-normal doses of the medicine are safe.
Johnson was the fifth patient to commit suicide after taking Cymbalta since clinical trials began several years ago. About one-fifth of the volunteers have quit the trial since her death. Johnson's suicide adds more controversy to the ongoing debate over whether antidepressants are associated with suicidal behavior in children and teenagers.
Eli Lilly announced that the company still expects the U.S. Food and Drug Administration to approve Cymbalta sometime in the summer of 2004.
See your doctor if you have experienced serious health problems after taking Cymbalta. In addition, it may be important to contact an attorney who can help you protect your legal rights. Please keep in mind that there may be time limits within which you must commence suit.
Attorneys associated with InjuryBoard.com will evaluate your case free of charge. In addition, you will not pay any fees unless your attorney recovers money for you. Please click on the free Ask An Attorney button to take advantage of this valuable service.
-- Article Courtesy of InjuryBoard.com
More ...
- Some Asthma Drugs Cause Bone Loss
- Hopkins Admits Responsibility in Death
- Several Die in Arsenic Trioxide Trials
.